In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean Region in Turkey

Medical Principles and Practice

Volumn 14, Issue 6, 2005, Pages 413-416

  Yamazhan, Tansu ^a   Aydemir, Şöhret ^a   Tünger, Alper ^a   Serter, Demir ^a   Gökengin, Deniz ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Agar dilution method; Antibiotic susceptibility; Brucella melitensis

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DIRITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; BRUCELLA MELITENSIS; BRUCELLOSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; HOSPITALIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TURKEY (REPUBLIC);

ACUTE DISEASE; ADULT; ANTI-INFECTIVE AGENTS; BRUCELLA MELITENSIS; BRUCELLOSIS; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; QUINOLONES; TURKEY;

EID: 26644472212     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088122     Document Type: Article

References (20)

1. Report of the Turkish Ministry of Health, Division of Communicable Diseases, May 2001.
2. Doganay M, Aygen B: Human brucellosis: an overview. Int J Infect Dis 2003;7:173-182.
3. Lang R, Rubinstein E: Quinolones for the treatment of brucellosis. J Antimicrob Chemother 1992;29:357-359.
4. Akova M, Uzun Ö, Akalin E, Hayran M, Ünal S, Gür D: Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother 1993;37:1831-1834.
5. Accocella GA, Bertrand J, Beytount J, Durrande JA, Garcia-Rodriguez J, Kosmidis M, Micoud M, Rey M, Rodriguez Z, Roux J, Stahl P: Comparison of the three difference regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother 1990;23:433-439.
6. Bosch J, Linares J, Lopez de Goicoechae MJ, Ariza J, Cisnal MC, Martin R: In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother 1986;17:459-461.
7. Kocagöz S, Akova M, Altun B, Gür D, Hasçelik G: In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect 2002;8:240-242.
8. Bodur H, Balaban N, Aksaray S, et al: Biotypes and antimicrobial susceptibilities of Brucella isolates. Scand J Infect Dis 2003;35:337-338.
9. Tunger O, Dinc G, Ozbakkaloglu B, Atman UC, Algun U: Evaluation of rational antibiotic use. Int J Antimicrob Agents 2000;15:131-135.
10. Joint FAO/WHO expert committee on brucellosis. World Health Organ Tech Rep Ser 1986;740.
11. Easmon CS, Crane JP, Blowers A: Effect of ciprofloxacin on intracellular organism in vitro and in vivo studies. J Antimicrob Chemother 1986;18:43-48.
12. al-Sibai MB, Halim MA, el-Shaker MM, Khan BA, Quadri SM: Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrob Agents Chemother 1992;36:150-152.
13. Akalin HE, Ünal S, Gür D, Baykal M: Ofloxacin in the treatment of brucellosis. Proc 3rd Int Symp on Quinolones, Vancouver, Canada. Eur J Clin Microbiol Infect Dis 1990;(special issue):326-328.
14. Martin IT, Sanchez EG, Martinez IM, Fresnadillo MJ, Sanchez EG, Rodriguez AG: In vitro activities of six new fluoroquinolones against Brucella melitensis. Antimicrob Agents Chemother 1999;43:194-195.
15. Garcia Rodriguez JA, Munoz Bellino JL, Fresnadillo MJ, Trujillano I: In vitro activities of new macrolides and rifapentine against Brucella spp. Antimicrob Agents Chemother 1993;37:911-913.
16. Landinez R, Linares J, Loza E, Martinez-Beltran J, Martin R, Baquero F: In vitro activities of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis. Eur J Clin Microbiol Infect Dis 1992;11:265-267.
17. Qadri HSM, Halim MA, Ueno Y, Abumustafa FM, Postle AG: Antibacterial activity of azithromycin against Brucella melitensis. Chemotherapy 1995;41:253-256.
18. Arda B, Tunçel M, Yamazhan T, Gökengin D, Gürel Ö: Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection. Int J Antimicrob Agents 2004;23:204-207.
19. Dhar R, Araj GF, Kisswani SM, Chugh TD: In vitro activity of conventional and newer antimicrobial agents in Brucella melitensis clinical isolates from Kuwait. Med Principles Pract 1990;2:110-117.
20. Rubinstein E, Lang R, Shasha B, Hagar B, Diamanstein L, Joseph G, Anderson M, Harrison K: In vitro susceptibility of Brucella melitensis to antibiotics. Antimicrob Agents Chemother 1991;35:1925-1927.